MFG
IRWD icon

Merit Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Merit Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$189K Sell
44,799
-9,908
-18% -$38.2K ﹤0.01% 2134
2026
Q1 		$192K Buy
54,707
+5,329
+11% +$21.8K ﹤0.01% 1943
2025
Q4 		$166K Buy
49,378
+499
+1% +$1.3K ﹤0.01% 1847
2025
Q3 		$64K Buy
48,879
+7,232
+17% +$7.49K ﹤0.01% 1764
2025
Q2 		$29.9K Buy
41,647
+26,325
+172% +$20.7K ﹤0.01% 1680
2025
Q1 		$22.5K Buy
+15,322
New +$36.5K ﹤0.01% 1386

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Merit Financial Group's IRWD Position: Q2 2026 in Review

Merit Financial Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 18% in Q2 2026, selling an estimated $38.2K and leaving 44,799 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Merit Financial Group first reported a position in IRWD in Q1 2025 and has held it in 6 quarters since. The position peaked at $192K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Merit Financial Group held 44,799 shares of Ironwood Pharmaceuticals worth $189K as of Q2 2026.
  • Merit Financial Group sold 9,908 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $38.2K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2134 holding.
  • Merit Financial Group first reported a position in Ironwood Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Merit Financial Group's Ironwood Pharmaceuticals position peaked at $192K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.